Proteomic characterization of primary and metastatic prostate cancer reveals reduced proteinase activity in aggressive tumors

Prostate cancer (PCa) is a heterogeneous group of tumors with variable clinical courses. In order to improve patient outcomes, it is critical to clinically separate aggressive PCa (AG) from non-aggressive PCa (NAG). Although recent genomic studies have identified a spectrum of molecular abnormalitie...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Qing Kay, Chen, Jing, Hu, Yingwei, Höti, Naseruddin, Lih, Tung-Shing Mamie, Thomas, Stefani N., Chen, Li, Roy, Sujayita, Meeker, Alan, Shah, Punit, Chen, Lijun, Bova, G. Steven, Zhang, Bai, Zhang, Hui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8460832/
https://www.ncbi.nlm.nih.gov/pubmed/34556748
http://dx.doi.org/10.1038/s41598-021-98410-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8460832/
https://www.ncbi.nlm.nih.gov/pubmed/34556748
http://dx.doi.org/10.1038/s41598-021-98410-0

Ejemplares similares